State-of-the-art drug-eluting metal stents are the gold standard for interventional treatment of
coronary artery disease. Although they overcome some disadvantages and limitations of …

Objectives: The aim of this study was to determine the risk of scaffold thrombosis (ST) after
percutaneous coronary intervention (PCI) with placement of an ABSORB bioresorbable …

The advent of intracoronary stents has greatly increased the safety and applicability of
percutaneous coronary interventions. One of the drawbacks of drug-eluting stents (DES) is …

The introduction of percutaneous treatment of coronary artery stenosis with balloon
angioplasty was the first revolution in interventional cardiology; the advent of metallic …

Bioresorbable scaffolds have the potential to introduce a paradigm shift in interventional
cardiology, a true anatomical and functional “vascular restoration” instead of an artificial stiff …

Aims: In this multicentre prospective registry we sought to evaluate the immediate and
midterm clinical outcomes following single or multiple overlapping bioresorbable vascular …

Objectives The purpose of this study was to describe the multimodal outcome 12 months
after implantation of coronary bioresorbable scaffolds (BVS) for the treatment of patients with …

Background Third-generation drug-eluting metal stents are the gold standard for treatment of
coronary artery disease. The permanent metallic caging of the vessel, however, can result in …

Background Bioresorbable vascular scaffolds (BVS) have become an emerging tool to treat
coronary artery disease. However, the current use of BVS is still widely restricted to stable …

Background: Safety and efficacy of bioresorbable vascular scaffolds (BRS) and the role of
postdilatation on outcome in acute coronary syndrome (ACS) patients compared with those …